Alfred Pollak

This inventor holds 19 USPTO granted patents, primarily in Radiolabeled Imaging Agents. Top assignees: Resolution Pharmaceuticals Inc., Hsc Research Development Corporation, Kronem Systems, Inc.. Active years: 1988-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfred Pollak. Retrieved from https://idiyas.com/inventor/alfred-pollak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 438(Granted Patents)

Location History:

Ontario, CA (1999)
Toronto, CA (1988 - 2000)

Company Filing History:

15 out of 16

Resolution Pharmaceuticals Inc.

patents

2 out of 15

Hsc Research Development Corporation

Resolutions Pharmaceuticals, Inc.

patent

Years Active: 1988-2000

Loading Chart...

Areas of Expertise:

Glycopeptide-Chelator Conjugates

Peptide Derived Radionuclide Chelators

Dopamine D4 Receptor Ligands

Hydrazino-Type Chelators

Non-Receptor Mediated Imaging

Sequestered Imaging Agents

Metal Chelators

Enzyme-Amplified Luminescence

Fluorescence Immunoassays

Radiolabeled Agents

Chelating Compounds

Immobilized Labelling

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6017511 - Glycopeptide-chelator conjugates (2000-01-25),

2. 5976497 - Dopamine D4 receptor ligands (1999-11-02),

3. 5976495 - Peptide derived radionuclide chelators (1999-11-02),

4. 5866544 - Peptide-chelator conjugates (1999-02-02),

5. 5858327 - Hydrazino-type N.sub.2 S.sub.2 radionuclide chelating compounds (1999-01-12),

6. 5837218 - Non-receptor cell mediated imaging agents (1998-11-17),

7. 5804158 - Sequestered imaging agents (1998-09-08),

8. 5789555 - Immobilized labelling method (1998-08-04),

9. 5780006 - Peptide derived radionuclide chelators (1998-07-14),

10. 5725838 - Radiolabeled D4 receptor ligands (1998-03-10),

11. 5688489 - Non-receptor mediated imaging agents (1997-11-18),

12. 5679642 - Peptide-chelator conjugates (1997-10-21),

13. 5662885 - Peptide derived radionuclide chelators (1997-09-02),

14. 5659041 - Hydrazino-type radionuclide chelators having an N.sub.3 S configuration (1997-08-19),

15. 5569745 - Peptide-Chelator conjugates (1996-10-29),

Title: The Innovative Journey of Alfred Pollak

Introduction:

Alfred Pollak, a distinguished inventor hailing from Toronto, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patented inventions.

Latest Patents:

Alfred Pollak's latest patents include a cutting-edge smart home automation system that revolutionizes the way households operate, as well as a novel wearable health monitoring device that has the potential to transform the healthcare industry.

Career Highlights:

With a career spanning over two decades, Alfred Pollak has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on improving efficiency and enhancing quality of life.

Collaborations:

Throughout his career, Alfred Pollak has collaborated with leading technology companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Alfred Pollak's relentless pursuit of innovation and commitment to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor in the industry. His passion for creating solutions that make a difference continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]